Top sgRNAs depleted from cells mapped to genes previously implicated in glioblastoma biology, including OLIG2, NOS2, EPAS1 (HIF2A), and AGAP-AS1 (30–33), validating our screening technique and approach (Supplemental Figure 2E). This evidence concerns the gene OLIG2 and glioblastoma.